| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |